Stay updated with breaking news from Subadra dravida. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
HYDERABAD: A novel stem cell based treatment for Covid-19 patients, developed by a startup incubated at the University of Hyderabad, has emerged as an alternative for treatment of the virus. The biotech startup, Transcell Oncologics, announced a cell based technology Hemato human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) that has anti-inflammatory and repairing properties. “From donated umbilical cord tissues, we have harvested and clinically processed adult MSCs that upon infusion in the patient s body would reduce cytokine storm (a protein) produced by the virus. They decrease the inflammation in the patient’s body triggered by the virus,” said Dr Subadra Dravida, founder chief executive officer, Transcell. ....
UoH startup develops stem cell-based treatment for COVID-19 By IANS| Posted by Neha | Updated: 3rd May 2021 11:15 pm IST University of Hyderabad Hyderabad: A biotech startup company, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy for COVID-19 patients. Transcell Oncologics has developed a proprietary cell-based platform technology, HEMATO UC-MSCs, with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities. The treatment is associated with a significant decrease in a set of inflammatory cytokines involved in the COVID-19 ‘cytokine storm’, with significantly improved patient survival and time to recovery. ....
Hyd varsity startup develops stem cell-based treatment for Covid By IANS | Published on Mon, May 3 2021 22:48 IST | 4 Views University of Hyderabad to allow 2K more students on campus. Image Source: IANS News Hyderabad, May 3 : A biotech startup company, incubated at the ASPIRE-Technology Business Incubator (ASPIRE-TBI), University of Hyderabad (UoH), on Monday announced a human umbilical cord (UC) tissue harvested and clinically processed adult Mesenchymal Stem Cells (MSCs) based therapy for Covid patients. Transcell Oncologics has developed a proprietary cell-based platform technology, HEMATO UC-MSCs, with anti-cytokine storm properties, anti-inflammatory attributes and repairing abilities. The treatment is associated with a significant decrease in a set of inflammatory cytokines involved in the Covid-19 cytokine storm , with significantly improved patient survival and time to recovery. ....